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Abstract
The paired-domain-containing Pax transcription factors play an important role in the development of a range of organ, tissue and cell
types. Although DNA binding elements and target genes for Pax proteins have been identified, how these proteins identify appropriate DNA
elements and regulate different genes in different cellular contexts is not well understood. To investigate the relationship between Pax
proteins and their targets, we have studied the in vivo and in vitro properties associated with wild-type and different mutant variants of the
Caenorhabditis elegans Pax protein EGL-38. Here, we characterize the properties of four mutations that result in an amino acid substitution
in the DNA binding domain of EGL-38. We find that animals bearing the different mutant alleles exhibit tissue-preferential defects in egl-38
function. The mutant proteins are also altered in their activity in an ectopic expression assay and in their in vitro DNA binding properties.
Using in vitro selection, we have identified binding sites for EGL-38. However, we show that selected sites function poorly in vivo as
EGL-38 response elements, indicating that sequence features in addition to DNA binding determine the efficacy of Pax response elements.
The distinction between DNA binding and activity is consistent with the model that other factors commonly play a role in mediating Pax
protein target site selection and function in vivo.
q 2005 Elsevier Ireland Ltd. All rights reserved.
Keywords: DNA binding; Transactivation; Transcriptional control; Pax transcription factor1. Introduction
Pax genes have been shown to play an important role in
the development of a range of different cell types, and to
promote cell proliferation and cell survival (reviewed by
Chi and Epstein, 2002). Pax genes encode transcription
factors that are identified based on the presence of a
conserved DNA binding domain called the paired domain.
Although four main classes of Pax proteins have been
identified, all Pax proteins share several features common to
the paired domain. The paired domain can interact with
DNA as a monomer across a relatively large stretch of DNA
of more than 20 bp, but it also has a modular structure of two
helix-turn-helix domains which can bind to DNA indepen-
dent of each other (Xu et al., 1995; Jun and Desplan, 1996;0925-4773/$ - see front matter q 2005 Elsevier Ireland Ltd. All rights reserved.
doi:10.1016/j.mod.2005.04.005
* Corresponding author. Tel.: C1 614 688 0043; fax: C1 614 292 4466.
E-mail address: chamberlin.27@osu.edu (H.M. Chamberlin).Kozmik et al., 1997; Jun et al., 1998; Xu et al., 1999a).
Many DNA sequences that bind Pax proteins have been
identified. However, how Pax proteins interact with DNA in
vivo, and how they recognize appropriate targets from
among all sequences that could act as PAX binding sites,
remain open questions.
Genetic studies have shown that each Pax protein acts in
the development of several different cell and organ types
(reviewed by Chi and Epstein, 2002). Different functions are
mediated through the regulation of different target genes,
suggesting that cellular context plays an important role in
Pax protein function. Thus other factors may allow the same
Pax protein to regulate one set of target genes in one cell
type, and a different set of targets in a different cell type. Pax
proteins may function in a combinatorial manner with other
proteins acting through separate enhancers (e.g. Brophy
et al., 2003). In addition, examples in which Pax proteins
form complexes or bind DNA synergistically with otherMechanisms of Development 122 (2005) 887–899www.elsevier.com/locate/modo
Table 1
etl-38 alleles differentially affect expression of lin-48
Percent of hindgut cells expressing lin-48Tgfp in trans-heterozygotes
egl-38
allele
egl-38 allele
s1775 sy294 n578 sy287 gu22 C
sy294 0
n578 73 70 94
sy287 5 10 79 34
gu22 12 12 91 38 42
C 100
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et al., 1996; Roberts et al., 2001; Jin et al., 2002; Miranda
et al., 2002; Sigvardsson et al., 2002; Di Palma et al., 2003).
While these studies suggest possible mechanisms for
combinatorial control, dissecting how a given Pax factor
participates in target gene expression in different cell types
in vivo remains an important question.
To better understand how a single Pax transcription
factor can regulate different target genes in different cells,
we have characterized the functions of the Caenorhabditis
elegans Pax2/5/8 gene egl-38. Genetic studies have shown
that egl-38 functions in the development of several different
cells and organ types including the egg-laying system, the
hindgut, and the development of male mating spicules
(Chamberlin et al., 1997). egl-38 also affects the expression
of different genes in the different cell types. For example,
expression of the epidermal growth factor gene lin-3 in the
hermaphrodite vulval cells is dependent on egl-38, whereas
the Ovo zinc finger transcription factor gene lin-48 is a
target for EGL-38 in hindgut cells (Chang et al., 1999;
Johnson et al., 2001). lin-48 is not expressed in the egg-
laying system, indicating it is a target in one cell type, but
not the other. Although egl-38 is an essential gene, its
different functions have been characterized using non-null,
reduction-of-function alleles that allow homozygotes to be
viable. These mutant alleles affect egl-38 in vivo function in
different ways, and each allele corresponds to a missense
mutation that alters an amino acid in the EGL-38 DNA
binding domain (DBD; Chamberlin et al., 1997, 1999; this
work). Consequently, to investigate the relationship
between Pax proteins and their in vivo targets, we have
tested the in vivo and in vitro properties of these mutant
EGL-38 variants.2. Results2.1. Identification of a new allele of egl-38
Non-null alleles of egl-38 have been previously ident-
ified in genetic screens for egg-laying defective mutants and
for mutants with abnormal male development (Trent et al.,
1983; Chamberlin et al., 1997, 1999). We carried out a
genetic screen for mutations that alter the expression of an
EGL-38 target gene lin-48 using a lin-48Tgfp transgene,
and identified a mutation, gu22, that affected expression of
lin-48 in hindgut cells. gu22 mutants also exhibit defective
hindgut and male tail development similar to that seen in
egl-38 mutants. We mapped gu22 to linkage group IV, and
showed that it fails to complement other egl-38 alleles
(Table 1 and data not shown). We sequenced the egl-38
genomic DNA from gu22 mutants, and identified a single
missense mutation affecting the DNA binding domain-
coding region of egl-38 (Fig. 1). Thus, an independent
screen for mutants defective in expression of an EGL-38target gene has identified a fourth egl-38 allele that alters the
DBD of the EGL-38 protein.2.2. Mutant alleles of egl-38 differentially affect its activity
in vivo
To compare the new egl-38(gu22) allele to previously
described alleles, and to extend the analysis of each allele
for a range of functions, we examined the phenotypes
associated with mutant animals (Table 2). Each allele was
tested for its effect on egg-laying ability and male tail
morphology, traits associated with egl-38 mutants that have
been described before (Chamberlin et al., 1997). In addition,
egg-laying function was characterized at the cellular level
by scoring the morphology of the vulF cells in L4 larval
stage hermaphrodites, and the excretory system function
was assessed by observing the position of the excretory duct
cell opening in L3 larval stage animals (Fig. 2). Expression
of lin-48Tgfp in hindgut cells was scored in animals
homozygous for each allele and in animals bearing different
transheterozygous allelic combinations (Table 1; Fig. 3).
Although each allele disrupts certain functions of egl-38, we
have found that they cannot be ordered into an allelic series,
going from weakest to strongest allele. Instead, the alleles
exhibit cell or tissue preferential defects compared to each
other. For example, in egl-38(gu22) and egl-38(sy287)
mutants, tail functions including male tail development and
lin-48 expression are disrupted, whereas a high level of
function in the egg-laying system is retained. In contrast,
egl-38(n578) mutants are defective in the egg-laying
system, but retain a high level of activity in the tail.
One possible interpretation of the loss-of-function
genetics is that there are differences in tissue-specific
stability, or subtle differences in protein activity for the
different protein variants. To further investigate the
differences among the mutants, we assessed the function
of EGL-38 proteins when they ectopically expressed in
animals under control of a heat-inducible promoter. We find
that induction of wild-type EGL-38 results in ectopic
expression of the target gene lin-48 and causes a stringent
lethality effect in embryos (Figs. 4,5). We tested the mutant
proteins in these ectopic expression assays, and found that
the different mutations alter EGL-38 activity to different
extents (Table 3, Figs. 4,5). For example, the protein
Fig. 1. Alignment of amino acid sequences of the paired domain from different Pax proteins. The paired domain from the C. elegans Pax2/5/8 protein EGL-38
(Chamberlin et al., 1997), human PAX2 (Eccles et al., 1992), the C. elegans Pax6 protein VAB-3 (Chisholm and Horvitz, 1995), and the Drosophila Paired
protein (Bopp et al., 1986) are shown. Identical amino acids are shaded with black, conserved amino acids are gray. Sequences were aligned using ClustalW 1.8
(Jeanmougin et al., 1998), and shaded using Boxshade 3.21 (http://www.ch.embnet.org/software/BOX_form.html). Structural features associated with each
domain are indicated below the sequence, with arrows indicating b-sheet and boxes indicating a-helical structure (Xu et al., 1995, 1999b). The amino acid
changes associated with each mutant allele are indicated above. Genomic DNA sequence analysis identified that gu22 corresponds to a missense transition
mutation of ATG (methionine) to ATA (isoleucine).
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position indicates position within the DBD) retains a high
level of activity in the lin-48Tgfp transactivation assay but
is defective in the viability assay. In contrast, protein
corresponding to the egl-38(sy294) allele (G33V) retains
more activity in the viability assay than it does in the lin-
48Tgfp transactivation assay. We speculate that the
lethality results from inappropriate expression of genes
downstream of EGL-38. Although we do not know what
gene or genes may be mediating the effect, the functional
differences between the different mutant proteins in the two
ectopic expression assays suggest it is not mediated through
lin-48. Taken together, the loss- and gain-of-function
genetic assays indicate that different mutations affecting
the EGL-38 DNA binding domain can preferentially affect
distinct functions of the protein.Table 2
egl-38 alleles preferentially affect different functions in vivo
egl-38
allele
DBD
change
Percent wild-type Microns (GSEM)
Egg-
laying
vulF
morph.
Male
tail
Ex. duct
C None 100 100 100 13.07 (G1.55)
sy287 G9S 100 90 10 13.96 (G1.29)
gu22 M29I 94 80 2 13.23 (G1.54)
sy294 G33V 27 67 0 27.53 (G3.16)
n578 G69E 0 4 74 13.53 (G1.62)2.3. Mutant alleles of egl-38 differentially affect the DNA
binding properties of the protein product
Since the different mutant alleles affect the DBD of EGL-
38, we asked whether they alter the DNA binding activity of
the protein. We expressed the DBD of wild-type and mutant
proteins in E. coli and tested their DNA binding ability in
vitro in an electrophoretic mobility shift assay (EMSA;
Fig. 6). As a probe, we used an endogenous DNA response
element from the lin-48 gene (termed lre2) that binds
recombinant wild-type EGL-38 with high affinity (Johnson
et al., 2001). We found that each mutation indeed affects the
DNA binding activity of the protein. In addition, although
the EMSA is not quantitative, the DNA binding exhibits
some correlation with the ability of each protein to
transactivate a lin-48Tgfp transgene in vivo. For example,
the protein corresponding to the egl-38(n578) allele (G69E)retains DNA binding activity in vitro and lin-48 transactiva-
tion activity in vivo, whereas the protein corresponding to
the egl-38(sy294) allele (G33V) is defective in both DNA
binding and transactivation. However, the G69E (n578)
protein and the M29I protein (corresponding to egl-
38(gu22)) exhibit similar DNA binding activity, but very
distinct activities in vivo (Tables 1–3; Fig. 5), suggesting
that DNA binding to this endogenous element is not the only
function that influences a protein’s ability to transactivate
lin-48.2.4. Selection of DNA binding sequences for wild-type
and mutant EGL-38 proteins
To further explore the DNA binding properties associ-
ated with wild-type and mutant proteins, we carried out an
in vitro DNA selection experiment. We reasoned that
selection with the wild-type protein might identify a range
of possible binding sites for EGL-38, and allow for a
comparison of DNA binding features between EGL-38 and
Pax2/5/8 proteins from other species that have also been
explored using DNA selection studies (Epstein et al., 1994;
Jun and Desplan, 1996). We also selected with mutant
D. egl-38(sy294)C. wild type
A. wild type B. egl-38(n578)
Fig. 2. egl-38 functions in morphogenesis of the egg-laying and excretory systems. In wild-type L4 larva hermaphrodites (A), the vulva cells separate, leaving a
thin laminar process between the vulva and the uterus (arrowhead). In egl-38 mutants (B), the cells often fail to separate, which contributes to the egg-laying
defect of the mutants. This is scored as a defect in vulF morphogenesis (vulF morph.) in Table 2. In wild-type animals (C), the excretory duct connects with the
cuticle at a more posterior position compared to some egl-38 mutants (D). The relative position can be measured as the distance of the pore opening to the base
of the posterior pharynx bulb in L3 larvae (white bracket; Table 2). Scale bars are 10 mm.
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Fig. 3. Expression of lin-48Tgfp is altered in egl-38 mutants. Nomarski DIC micrographs (A, C) of L1 larvae, and epi-fluorescent micrographs (B, D) of the
same animals. Wild-type animals bearing a lin-48Tgfp transgene (pTJ1157) express GFP in hindgut cells (arrowhead, B), whereas egl-38(sy294) mutants do
not (arrowhead, D). E. lin-48Tgfp transgenes used in this study, after Johnson et al. (2001). pTJ972 is a genomic clone that can rescue all lin-48 defects and is
included for comparison to pTJ1157 and pAJ49. Rectangles correspond to lin-48 exons, and ovals correspond to the two redundant EGL-38 responsive
elements, lre1 and lre2. pTJ1157 includes both EGL-38 responsive elements, and mediates a robust response to EGL-38. This clone is included in the saIs14
transgene used for the experiments summarized in Tables 1 and 3. pAJ49 is a truncated form of pTJ1157 that includes only lre2. This clone was used as the
control and the template for the experiments summarized in Fig. 11. Use of the truncated clone for these experiments ensures that the EGL-38 response is
mediated through a single response element.
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Fig. 4. Ectopic expression of EGL-38 induces ectopic lin-48Tgfp
expression. (A) Heat-treated embryos bearing a lin-48Tgfp transgene
exhibit a low level of GFP in the intestine. This low-level intestine
expression is observed in all lin-48Tgfp-bearing animals under normal
culture conditions. (B) Heat-treated embryos bearing both a hspTegl-38
(C) and a lin-48Tgfp transgene show a high level of GFP, corresponding to
ectopic expression of the lin-48Tgfp transgene. The ectopic expression is
commonly restricted to the posterior ectoderm (as in this embryo). This
restricted ectopic expression may correspond to cells that contain the
appropriate additional factors to promote lin-48 expression. (C) Western
blot of hspTegl-38 transgene-bearing strains to demonstrate expression of
proteins tagged with a FLAG epitope. Although the hspTegl-38(sy287)
strain exhibits lower protein levels than the others, this strain exhibits a high
level of egl-38 activity in functional assays (Fig. 5 and Table 3).
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Fig. 5. Ectopic expression of EGL-38 affects embryonic viability. The
graph shows the percentage of eggs that hatch following heat-shock
treatment. The bars correspond to the average percentage of survivors from
three independent trials, with brackets indicating SEM. Induced ectopic
expression of wild-type egl-38 results in embryonic lethality (hspTegl-
38(C)). This activity is disrupted to different extents by mutations that
correspond to the different genetic alleles. Wild-type embryos (no
transgene) exhibit some lethality which results from the heat-shock
treatment.
Table 3
Ectopic expression of EGL-38 induces ectopic expression of lin-48
Transgene Ectopic lin-48Tgfp (%) N
none 0 16
hspTegl-38(C) 73 26
hspTegl-38(sy287) 80 25
hspTegl-38(sy294) 7 14
hspTegl-38(n578) 60 20
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selected by mutant proteins to those selected by the wild-
type protein. The rationale for these selections was to test
the hypothesis that the mutations preferentially affect EGL-
38 function by affecting the ability of the protein to bind to
certain target sequences, but not others. One prediction of
this hypothesis is that the mutant proteins might select
sequences that represent a subset of the sequences selected
by the wild-type protein, and that sequences selected by onemutant protein might not bind to other mutant proteins.
Oligo selection from a pool of double-stranded DNAs
containing a 25-mer of random nucleotides was carried out
for each EGL-38 variant. The resulting selected DNAs were
cloned and sequenced. Wild-type, M29I (gu22), and G9S
(sy287) proteins selected multiple sequences from which
consensus sequences were derived (Fig. 7). The sequences
selected by the wild-type protein are similar to those
recovered in similar selections using Pax2 or Pax8 proteins
(Epstein et al., 1994; Jun and Desplan, 1996), and similar to
that of the endogenous lin-48 element lre2. Under the same
selection conditions G69E (n578) and G33V (sy294)
proteins each selected variants of a distinct single sequence
(Fig. 8).
To test the function associated with the selected
sequences, we focused on three representative elements:
an ‘optimal’ sequence derived from the sequences selected
by wild-type EGL-38, the sequence selected by G33V
(sy294), and the sequence selected by G69E (n578). These
sequences were chosen due to the different in vivo functions
associated with each selecting protein. Specifically, wild-
type protein retains all EGL-38 activities, the G69E (n578)
protein retains a high level of lin-48 transactivation activity,
and the G33V (sy294) protein is defective in lin-48
transactivation (Tables 1 and 3). The selected sequences
wild type
G9S
sy287
G33V
sy294
G69E
n578
M29I
gu22 vecto r—
1 2 4 6 8 10 11 12 13
EGL-38 protein
free
probe
3 5 7 9
Fig. 6. DNA binding ability is affected in mutant EGL-38 proteins. Two
dilutions (1:20 and 1:40) of wild-type and mutant EGL-38 DNA binding
domain cell lysates were incubated with a probe corresponding to the
endogenous response element from lin-48, lre2, and separated on a 6%
polyacrylamide gel. Vector lanes (12, 13) contain lysates from cells
expressing the pET-32 vector without egl-38 cDNA. Lane 1 (–) includes no
lysate (probe only).
G. Zhang et al. / Mechanisms of Development 122 (2005) 887–899892were tested by altering lre2 oligos as illustrated in Fig. 8. In
an EMSA, we found that the ‘optimal’ sequence bound
wild-type protein better than mutant protein, whereas the
sequences selected by G33V (sy294) and G69E (n578) show
similar binding to all three proteins (Fig. 9). Thus, although
the selection experiment indeed selected for sequences that
bind mutant proteins, at least some of the recovered
sequences do not preferentially bind one protein over
another. Nevertheless, from the in vitro selection experi-
ment we conclude that EGL-38 can select sequences similar
to those selected by other Pax proteins, and that there areFig. 7. Different EGL-38 variants select distinct sequences in vitro. The sequences
EGL-38, EGL-38 M29I (gu22) and EGL-38 G9S (sy287). Each sequenced clone
sequence, upper case letters indicate non-random consensus P!0.01, lower case l
clone that match the consensus are underlined. Selections with EGL-38 G33V (sy2
7 to 8 sequenced clones. The sequences selected by these two proteins is listed isequences that the mutant proteins can bind to as effectively
as do wild-type proteins.2.5. Features in addition to binding affinity play a critical
role in the in vivo function of an EGL-38 response element
Although, we did not identify DNA sequences that
preferentially bind one mutant protein over another in the
selection experiment, we did identify a sequence that
preferentially binds wild-type protein and thus behaves like
the endogenous lre2, as well as two sequences that can bind
wild-type and mutant proteins. To better understand the
features that contribute to an effective EGL-38 response
element in vivo, we compared the properties of these
sequences selected in vitro to the endogenous EGL-38
response element lre2 in in vitro and in vivo assays. To
compare DNA binding affinity, we carried out an EMSA
competition assay (Fig. 10). We observed that in vitro, each
selected sequence competes at least as well as lre2 for
binding to wild-type EGL-38.
To test the function of the selected sequences in vivo, we
incorporated each element into a reporter transgene by
altering the endogenous lre2 site in a lin-48Tgfp reporter
clone (pAJ49; see Fig. 3). This clone is different from the
one used in Table 1, in that it includes only one EGL-38
response element (lre2), rather than two EGL-38 response
elements (lre1 and lre2). Thus, the effectiveness of the
response element in the lre2 position can be assayed, as
the clone lacks the redundant element that can mediate the
response to EGL-38. However, with only one functional
response element, the transgenes are not as robust, andobtained after successive rounds of selection with the DBD from wild-type
is listed, with a summary sequence below each column. In the summary
etters indicate non-random consensus, 0.01!P!0.05. Nucleotides in each
94) and EGL-38 G69E (n578) identified essentially identical sequence from
n Fig. 8.
Fig. 8. Summary of Pax binding sequences. Nucleotide position corresponds to position from Xu et al., (1999a). Based on the structure of Pax6 protein bound to
DNA, EGL-38TDNA contacts are predicted to extend from positions 2 to 22, with the more amino-terminal portion of the paired domain associated with
sequences to the left, and the carboxyl-terminal portion associated with sequences to the right. Sequence is shaded according to its match with the EGL-38
response element lre2. Black indicates a sequence match to lre2, and gray indicates one of two common nucleotides matches. (A) Composite sequence selected
by Pax2 (Epstein et al., 1994). (B) Endogenous sequence lre2 from the EGL-38 target gene lin-48 (Johnson et al., 2001). (C–G) Summary of EGL-38 selected
sequences. (H–J) Sequence alterations tested in vitro and introduced into the lre2 site of lin-48 (Figs. 9–11). ‘Optimal’ indicates a consensus from sequences
selected by wild-type EGL-38 protein. G33V (sy294)-s and G69 (n578)-s indicate sequence selected by the protein from egl-38(sy294) and egl-38(n578)
mutants, respectively. Each variant incorporates selected nucleotides into the context of an lre2 oligo or transgene. Changes from the lre2 element are not
shaded, and are also indicated in lower-case italics.
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compared to full length transgenes containing both response
elements (Johnson et al., 2001). Nevertheless, altering the
lre2 element in this reporter provides an in vivo context to
compare the function of an endogenous DNA binding
element to those selected in vitro. Surprisingly, we found
that selected sequences all function poorly when tested in
wild-type animals. The ‘optimal’ sequence failed to mediate
an EGL-38 response, whereas the sequence elements
selected by G33V (sy294) and G69E (n578) mediated a
reduced level of response (Fig. 11). In general, each selected
element functions less efficiently as an EGL-38 response
element than does the endogenous lre2.free
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Fig. 9. EGL-38 proteins bind selected sequences in vitro. A 1:30 dilution of
protein lysates including wild-type and mutant EGL-38 proteins were
incubated with probes corresponding to different selected sequences
(‘optimal’ G33V (sy294)-s, and G69E (n578)-s selected sequences are
shown in Fig. 8). Vector lanes contain lysates from cells expressing the
pET-32 vector without egl-38 cDNA. –, indicates oligo only (no lysate).To test whether the altered response elements simply
reduce the response of the reporter transgene to endogenous
EGL-38, we introduced the two altered transgenes that
retained some activity into different egl-38 genetic mutant
backgrounds. The endogenous lre2 element exhibits differ-
ential responses, with lin-48Tgfp expression still observed
in egl-38(n578) mutants, but an absence of expression in
egl-38(sy294) mutants (Fig. 11). This reporter gene
response is similar to the level of activity that each allele
retains with respect to hindgut cell development (Johnson
et al., 2001). In contrast, the transgenes modified to contain
the selected sequences exhibited a similar, low level of
activity in each egl-38 genetic background. This result
shows that the mutant proteins (e.g. the G33V protein in the
egl-38(sy294) mutant that normally cannot transactivate lin-competitor
5 10 100 5 10 100 5 10 100 5 10 100 100none 
lre2 “optimal”
G33V-s
(sy294)
G69E-s
(n578) lre1
—
1 3 5 7 9 10 11 12 13 14 15
free
probe
2 4 6 8
Fig. 10. Comparison of EGL-38 binding to endogenous and in vitro selected
sequences. A 1:30 dilution of wild-type EGL-38 DBD cell lysates were
incubated with the lre2 probe and increasing-fold unlabeled competitor
oligo. Sequences corresponding to lre2, ‘optimal’ G33V(sy294)-s, and
G69E(n578)-s are shown in Fig. 8. lre1 is an element from the lin-48 gene
that can mediate the response to EGL-38, but does not bind the protein in
vitro (Johnson et al., 2001), and serves as a negative control. –, indicates
oligo only (no lysate).
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egl-38 genotype
wild type lre2 (+)
"optimal"
G33V(sy294)-s
G69E(n578)-s
lre2 (+)
G33V(sy294)-s
G69E(n578)-s
lre2 (+)
G33V(sy294)-s
G69E(n578)-s
wild type
wild type
wild type
egl-38(n578)
egl-38(n578)
egl-38(n578)
egl-38(sy294)
egl-38(sy294)
egl-38(sy294)
Expression
in hindgut
(av. cells/animal
 +/– s.e.m.)
2.75 +/– 0.21
0.00 +/– 0.00
1.10 +/– 0.16
0.89 +/– 0.16
0.88 +/– 0.15
0.63 +/– 0.14
0.71 +/– 0.15
0.00 +/– 0.00
1.30 +/– 0.15
0.42 +/– 0.12
Fig. 11. The endogenous lre2 element is a more effective EGL-38 response element than are in vitro selected sites. lin-48Tgfp transgenes bearing the
endogenous (lre2) or modified EGL-38 response element were tested for their ability to promote GFP expression in the four hindgut cells that normally can
express the transgene. The data are presented in two ways. Graphically, with the percentage of total cells expressing GFP (black bar) or not expressing GFP
(white bar). Numerically, with the average number of cells expressing per animal, GSEM. The percent expression for lre2-based transgenes in this figure is
lower than those reported in Table 1 because this assay uses extrachromosomal transgenes with only one EGL-38 response element (lre2), whereas the
transgene in Table 1 is integrated into a chromosome and contains two EGL-38 response elements (lre1 and lre2; see Fig. 3). N, number of animals scored (four
cells are scored for each animal).
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response element to which they can bind. Each protein
(wild-type and mutant) can act through the selected
sequences equally well, but with reduced efficiency
compared to how wild-type protein acts through the
endogenous lre2 element. Overall, the selected sequences
reduce the efficacy of the response, but also change how the
target gene responds to the different EGL-38 proteins in a
cellular context.3. Discussion
3.1. Alterations to a Pax protein DNA binding domain can
affect its function in a tissue-preferential manner
DNA binding affinity is a key component of transcrip-
tion factor function. Our results with EGL-38 indicate that
mutations in the DNA binding domain of Pax proteins can
alter their DNA binding and their in vivo activity. Many
mutations that affect the DNA binding domain of Pax
proteins have been characterized previously (Tang et al.,
1997; DeStefano et al., 1998; Vilain et al., 2001;
Jumlongras et al., 2004). However, since we have
characterized several alleles and functions of egl-38, wehave been able to demonstrate that the alleles that affect
the DBD of EGL-38 can preferentially affect its activity in
certain functions, but not others. Our results with EGL-38
suggest one of two possible models to explain the tissue-
preferential effects. One possibility is that the different
mutant alleles affect the ability of EGL-38 to bind to
certain sequences, but not others. This model predicts that
either there are one or a few key targets in each cell type,
or that there are specific response element sequences that
are associated with all the targets for EGL-38 in a
particular cell type. An alternative model is that, although
the mutations affect DNA binding, their tissue preferential
effects result from their impact on EGL-38 function in
combination with other proteins that influence target
sequence recognition in vivo. This model predicts that
there would be cell-specific co-factors that function with
EGL-38 and participate in identifying which sequences
correspond to an appropriate DNA binding site or that
enhance EGL-38 transactivation activity. It also suggests
that the interaction between the co-factor and EGL-38
would be mediated, or otherwise affected, by the EGL-38
DBD. Although we favor the second model, clearly
distinguishing between the two will require identification
of proteins that act with EGL-38 and a large collection of
cell-specific EGL-38 target genes.
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gene transactivation
Our results with sequences selected by EGL-38 wild-
type and mutant proteins indicate that DNA binding affinity
is only one feature that influences whether a sequence acts
as a response element for Pax proteins. Indeed, altering the
endogenous lre2 response element to a sequence that binds
EGL-38 protein in vitro with high affinity both reduces the
overall effectiveness of the element, and also alters the
nature of how the element responds in different egl-38
genetic backgrounds. Whereas the endogenous sequence
responds to the different mutant proteins in a manner similar
to the apparent cell-specific in vivo function associated with
each allele, the elements selected in vitro respond similarly
in each genetic background, suggesting that the functional
properties of the in vitro assay are not the same as those in
vivo. This may be either because the DNA is presented to
the protein differently in vivo compared to in vitro, EGL-38
protein is modified in vivo in a manner different from in
vitro, or because other proteins influence how EGL-38 binds
DNA in a cellular context. However, we have not ruled out
an alternative possibility that each of the altered sequences
changes the normal EGL-38 binding element to one that
now binds a different protein that can compete with EGL-38
in vivo.
Previous studies have shown that although Pax proteins
can bind DNA as monomers, they can also form complexes
with other transcription factors. For example, Pax5 and Ets
transcription factors form a complex on the mb-1 promoter
that results in improved DNA binding affinity compared to
that seen with either protein alone (Fitzsimmons et al.,
1996). Complex formation between Pax5 and Ets is
mediated through the b-hairpin domain of the EGL-38
DBD (Wheat et al., 1999). In vitro, EGL-38 and C. elegans
Ets proteins can also form ternary complexes on DNA
(Fitzsimmons et al., 2001). Although genetic experiments
have not identified a role for C. elegans Ets genes in
regulating lin-48 (H.M.C., unpublished), these studies
demonstrate that the DBD can play roles in both DNA
binding and protein interaction. We find in our current
studies that the DNA binding ability of the different EGL-38
mutant proteins is affected. However, the tissue-preferential
features may also reflect disruption of specific protein
interactions mediated by the DBD. In the current exper-
iments, we have only tested one response element in one
gene. However, many endogenous response elements
identified for other Pax proteins also exhibit lower in vitro
DNA binding affinity compared to ‘optimal’ sequences
(Czerny et al., 1993). We speculate that the sub-optimal
features of endogenous Pax binding sites might indicate a
common role for other factors in the recognition of in vivo
Pax response elements. This combinatorial control would
allow for the recognition of Pax targets in both a cell-
specific and sequence-specific manner.4. Materials and methods
4.1. Caenorhabditis elegans strains
Caenorhabditis elegans strains were cultured according
to standard techniques (Sulston and Hodgkin, 1988). Muta-
tions are described in wormbase (http://www.wormbase.org/).
Mutations used: unc-119(e2498) III; unc-22(s7), dpy-
20(e1282), egl-38(n578), egl-38(sy294), egl-38(sy287), egl-
38(gu22), egl-38(s1775) IV; him-5(e1490) V. Integrated
transgene: saIs14 (lin-48Tgfp; Sewell et al., 2003).
4.2. Identification and characterization of egl-38(gu22)
gu22 was identified in a genetic screen for mutations that
result in reduced expression of a lin-48Tgfp reporter
transgene in hindgut cells. Fourth larval stage P0 hermaph-
rodites from the strain CM3 (unc-119(e2498); him-
5(e1490); saIs14) or CM117 (unc-119(e2498); saIs14)
were mutagenized with 50 mM EMS for 4 h (Sulston and
Hodgkin, 1988), placed individually on agar plates, and
allowed to produce self-progeny for two generations. F2
animals were screened for reduced expression of lin-48Tgfp
in the hindgut, a trait that phenocopies the expression
pattern in egl-38 mutants. From a screen of about 18,000
mutagenized gametes, several mutations were recovered,
one of which was a new allele of egl-38 (gu22). gu22 was
mapped to LGIV by crossing with mapping strains
containing markers from each linkage group: MT3751
(dpy-5(e61) I; rol-6(e187) II; unc-32(e189) III) and MT464
(unc-5(e53) IV; dpy-11(e224) IV; lon-2(e678) X). gu22
exhibited linkage with unc-5(e53), but not the other
markers. Failure to complement egl-38 was tested by
crossing gu22 heterozygous males with dpy-20(e1282) egl-
38(sy294) hermaphrodites, and observing egl-38-pheno-
types among the non-Dpy cross progeny.
4.3. Phenotypic analysis
Quantification of egg-laying ability, male tail mor-
phology, lin-48Tgfp expression, vulval morphology, and
excretory duct cell position was carried out as previously
described (Chamberlin et al., 1997; Johnson et al., 2001),
and as detailed below. Each phenotype was analyzed in at
least 25 animals for each genotype.
For lin-48Tgfp (Table 1; Fig. 3), the transgene saIs14
was used. This transgene contains the pTJ1157 reporter
gene with the upstream regulatory sequences from lin-48
that include both identified EGL-38-responsive elements
(lre1 and lre2; Fig. 3E). In wild-type animals, these elements
exhibit functional redundancy, but transgenes containing a
single response element exhibit enhanced sensitivity in
different egl-38 genetic backgrounds (Johnson et al., 2001).
Thus, the most robust EGL-38 response is mediated through
both elements. Trans-heterozygous animals were created by
crossing saIs14-bearing males with unc-22(s7) egl-38(x)
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were crossed to dpy-20(e1282) egl-38(y)/DnT1 hermaphro-
dites. Twi (Unc-22 heterozygotes) non-Unc (non-DnT1)
animals were scored. egl-38(s1775) is a lethal allele that
behaves as a genetic null for egl-38 (Chamberlin et al.,
1997).
To quantify vulF cell morphology, L4 animals were
observed under Nomarski optics (Table 2, Fig. 2). When the
vulval nuclei anterior and posterior to the anchor cell
separate, a thin laminar process is formed between the vulva
and uterus. In egl-38 mutants the vulval nuclei separate to a
lesser extent, and the tissue between the vulva and uterus
remains thick (Chamberlin et al., 1997).
Quantification of the positioning of the excretory duct
opening was done by measuring the distance from the
excretory pore to the base of the posterior pharynx bulb in
L3 animals as previously described (Table 2, Fig. 2; Wang
and Chamberlin, 2002).
4.4. Ectopic expression of EGL-38 proteins in worms
A cDNA coding for full-length wild-type EGL-38
protein was cloned downstream of the hsp16–41 promoter
in the vector pPD49.83 (a gift from A. Fire). Sequences
corresponding to the FLAG epitope were introduced in-
frame at the 3 0 end of the cDNA to allow detection of the
expressed protein. This construct represents hspTegl-38
(C) and also served as the template to produce egl-38 mutant
variants using the QuikChange mutagenesis method (Stra-
tagene). Mutant clones were sequenced to confirm the clone
and ensure that additional mutations were not incorporated
during the mutagenesis process. Transgenes for the heat-
inducible constructs were produced by microinjection of
plasmid DNA into the mitotic germline of hermaphrodites
according to the method of Mello et al. (1991). For all
experiments, 40–50 ng/ml experimental clone was co-
injected with 15 ng/ml pDP#MM016 (unc-119(C) plasmid;
Maduro and Pilgrim, 1995) into unc-119(e2498) animals.
The resultant extrachromosomal transgenes were integrated
into the chromosome by treating transgene-bearing animals
with 3.0–3.5 kRad gamma irradiation, and selecting for
stable transgene transmission in subsequent generations
following the protocol of Inoue et al. (2002).
Integrated transgenes were back-crossed several times,
and tested for protein expression level following heat
induction of the transgene using western blotting (Fig. 4).
Protein expression was visualized by subjecting mixed-
stage animals to a 35C heat-shock for 30 min. After 30 min
recovery at room temperature, worms were washed 2! in
M9 buffer, and frozen in liquid nitrogen. Thawed pellets
were sonicated in SDS-PAGE buffer, boiled for 5 min, and
separated by SDS-PAGE. Proteins were transferred to
membrane, blocked overnight with 5% non-fat dried milk
in PBS plus 0.1% tween, then washed 1! with PBS tween.
Proteins were detected with anti-FLAG and anti-a-tubulin
antibodies (Sigma) diluted 1:100.4.5. Functional assays of ectopically expressed
EGL-38 proteins
The activity of ectopically expressed EGL-38 proteins
was assessed by characterizing its impact on lin-48
transactivation and on embryonic viability. For lin-48
transactivation, 50 ng/ml of the lin-48Tgfp clone pTJ1157
(Fig. 3; Johnson et al., 2001) was co-injected with 180 ng/ml
pRF4 (rol-6(d); Mello et al., 1991) into animals bearing the
integrated hspTegl-38 transgenes. Expression of lin-
48Tgfp in the expected pattern (Fig. 3B) was confirmed
in the resulting transgenic lines. Transgene-bearing her-
maphrodites were allowed to lay eggs for 5–12 h, and then
removed from the plate. The eggs were subjected to a 35C
heat shock for 30 min, followed by incubation at 15C for
10–11 h, and analysis for expression of GFP. The data of
Table 3 are all from embryos prior to elongation, but with
clear differentiation and alignment of intestinal cells.
For viability, transgene-bearing hermaphrodites were
allowed to lay eggs for 5 h, removed from the plate, and the
eggs were counted. The eggs were then subjected to a 35 8C
heat-shock for 30 min. On the second day, the eggs and
resulting larvae were subjected to a second heat-shock
treatment. On the fourth day, the number of larvae at
different developmental stages was counted, and the number
of dead eggs was inferred by comparing resulting larva to
number of eggs counted on the first day. The data in Fig. 5
result from three independent trials. Each trial included 50
or more eggs for a given genotype. We have found that all
embryos are sensitive to heat shock. However, heat
treatment for 30 min at 35 8C induces transgene expression
yet permits significantly greater embryonic survival than
other heat treatment protocols such as those used for larvae
(32–33 8C for 1–2 h). Nevertheless, about half of control
embryos do not survive heat-shock treatment.
4.6. EGL-38 protein expression and EMSA
Production of recombinant EGL-38 DNA binding
domain (EGL-38 DBD) in E. coli was carried out as
described previously (Johnson et al., 2001). Briefly, cDNA
coding for amino acids 29–156 was amplified using RT-
PCR and cloned into vector pET-32 (Novagen). This
construct also served as the template to produce egl-38
mutant cDNA using the QuikChange method (Stratagene).
Mutant clones were sequenced to confirm the clone and
ensure that additional mutations were not incorporated
during the mutagenesis process. Recombinant EGL-38
DBDs were expressed in E. coli strain BL21 (DE3)
(Novagen). Cells were lysed with sonication in buffer Z
(Fitzsimmons et al., 2001). Recombinant protein expression
was confirmed with SDS-PAGE, and expressed protein
amount was estimated by comparing dilutions to known
quantities of BSA. For the experiments, lysates were
utilized that included similar levels of expressed recombi-
nant protein. Cell lysates, rather than purified protein, were
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have found that purification of Pax proteins significantly
reduces their activity (Fitzsimmons et al., 2001). In all
cases, lysates derived from cells expressing the pET-32
vector with no cDNA insert was used as a negative control.
All the oligonucleotides used are illustrated in Fig. 8,
except for lre1 which is described in Johnson et al. (2001).
Probes were purified on a polyacrylamide gel, and labeled at
the 3 0 end with digoxigenin (Roche). 0.8 ng of each labeled
oligonucleotide probe was used in EMSA. The binding
reactions were carried out in a 20 ml volume including 1!
binding buffer (10 mM Hepes, pH 7.9; 50 mM NaCl;
0.1 mM DTT; 1 mM EDTA; 5% glycerol; and 0.25%
BSA), 2 mg poly[d(I-C)], 0.2 mg L-lysine, and 1 ml diluted
1:20, 1:30 or 1:40 cell lysate. These dilutions were selected
to better observe the relatively weak binding of the EGL-38
mutant proteins. For the competition assay (Fig. 10), labeled
and unlabeled oligo were mixed together prior to adding the
cell lysate to the reaction. An equal amount of labeled oligo
was used for each reaction. The reactions were incubated at
room temperature for 30 min, then loaded on a 6%
polyacrylamide gel in 1X TGE buffer for electrophoresis.
The oligonucleotides were transferred to membrane by
electroblotting. Digoxigenin label was detected using
chemiluminescence (Roche).
4.7. In vitro DNA binding site selection
An 83-bp oligonucleotide containing 25 degenerate
bases was used as described in Epstein et al. (1994). One
hundred nanograms of double-stranded oligomer were used
for each round of selection. The selection reactions were
carried out in a 20 ml volume containing 1! binding buffer
(above), 2 mg poly [d(I-C)], 0.2 mg poly L-lysine, and 4 ml
cell lysate. Selection with lysates derived from cells
expressing the pET-32 vector with no insert was used as a
negative control. These control lysates selected DNAs
unrelated to those selected by the EGL-38 protein variants
(data not shown). The reactions were incubated at room
temperature for 30 min with gentle mixing by flicking the
tubes every 5 min. Next, 20 ml Ni-NTA Magnetic Agarose
Beads (QIAGEN) and 20 mM imidazole were added. The
reactions were incubated on ice for 1 h with gentle flicking
to allow the DNA-protein complex to bind to the beads. The
beads were separated from the supernatant using a Magnetic
Particle Concentrator (Dynal A.S., Oslo, Norway). The
beads were washed once with 250 ml 1! binding buffer
containing 20 mM imidazole, and then twice with 500 ml
washing buffer (50 mM NaH2PO4, 50 mM NaCl, 20 mM
imidazole, pH 8.0). The washing buffer was removed with
the concentrator. Selected oligomer was eluted with 25 ml
elution buffer (50 mM NaH2PO4, 50 mM NaCl, and
250 mM imidazole, pH8.0). The oligomer was amplified
by PCR using primers A and B (Epstein et al., 1994). The
PCR products were purified on a 15% polyacrylamide gel,
then used for the next round of selection. After five roundsof selection, the selected sequences were used as the probe
in an EMSA assay, but shifted bands were not detected.
Consequently, four additional rounds of selection were
carried out. Selected sequences were cloned into pBluscript
SK (C).4.8. Analysis of selected sequences
Clones were sequenced at the OSU Cancer Center
Genotyping and Sequencing Unit. Sequences were aligned
using SeqApp (http://www.iubio.bio.indiana.edu), and ana-
lyzed using Gibbs Recursive Sampler (Thompson et al.,
2003) with manual editing to identify summary sequences
(Fig. 7). For each position in the summary sequence,
nucleotide distributions that were non-random by Chi-
square analysis (P!0.01 for upper case letter, 0.01!P!
0.05 for lower case letter) were included in the summary
(Figs. 7,8).4.9. Construction and analysis of modified lin-48Tgfp
transgenes
Alterations to the EGL-38 response element lre2 were
made in the clone pAJ49 (Fig. 3E). This clone incorporates
regulatory sequences from lin-48 upstream of the coding
sequences for green fluorescent protein (GFP). It is a
truncated form of pTJ1157 that lacks the redundant element
lre1, allowing lre2 to be the only EGL-38 response element
influencing GFP expression in hindgut cells (Johnson et al.,
2001). Although the most robust response is obtained from
transgenes with both lre1 and lre2, it is necessary to use this
compromised transgene for this assay so that the redun-
dancy between lre1 and lre2 does not interfere with our
ability to assess the function associated with the altered
response elements. The nucleotide changes corresponding
to each selected sequence variant were incorporated to
precisely alter lre2 using either the QuikChange method
(Stratagene) or a two-step, PCR-based method (Ausubel
et al., 2000). Altered clones were sequenced to confirm that
the desired change was incorporated. Transgenes for the
reporter constructs were produced by microinjection of
plasmid DNA into the mitotic germline of as described
above. For all experiments that test expression of the
original or altered lin-48Tgfp, 40–50 ng/ml reporter clone
was co-injected with 15 ng/ml pDP#MM016 (unc-119(C)
plasmid; Maduro and Pilgrim, 1995) into unc-119(e2498);
him-5(e1490) animals. GFP expression levels were assessed
in L1 and L2 animals as previously described (Johnson
et al., 2001). As egl-38 genotype and the lre2 response
element do not affect the expression of lin-48 in other cell
types, each animal was confirmed to carry the transgene
based on expression of GFP in head cells prior to scoring the
four hindgut cells that are normally capable of expressing
lin-48Tgfp.
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